Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Silvia M. Ferrucci"'
1
Akademický článek
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus
Autor: Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G. Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M. Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T. Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Publikováno v: Dermatology and Therapy, Vol 14, Iss 4, Pp 919-932 (2024)
Abstract Introduction Several systemic therapies have been approved for the treatment of severe AD. In particular, Janus kinase inhibitors (JAKi), including abrocitinib, baricitinib, and upadacitinib, recently received approval for the treatment of p
Externí odkaz: https://doaj.org/article/7023be759f84421298febcd280592b42
Zobrazit plný text záznamu
5
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
Autor: Marjolein de Bruin-Weller, Andrew E. Pink, Silvia M. Ferrucci, Annalisa Patrizi, Ake Svensson, Marie L. A. Schuttelaar, Marie Tauber, Marius Ardeleanu, Shyamalie Jayawardena, Moataz Daoud
Publikováno v: Journal of dermatological treatment, 33(5), 2565-2570. Taylor & Francis Ltd
Background The European Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (EUROSTAD) is an ongoing observational study aiming to describe characteristics of patients with atopic dermatitis (AD) treated wi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dbeb4b8b3bb5fc750c21c0fea630c72
https://doi.org/10.1080/09546634.2022.2038361
Zobrazit plný text záznamu
6
331 Prior treatment usage in patients with atopic dermatitis initiating dupilumab: an update from the GLOBOSTAD registry
Autor: Silvia M Ferrucci, Mariateresa Rossi, Daria S Fomina, Hilde Lapeere, Wen-Hung Chung, Thrasyvoulos Tzellos, Anne-Claire Fougerousse, Jiangming Wu, Kwinten Bosman, Marius Ardeleanu
Publikováno v: British Journal of Dermatology. 188
The efficacy and safety of dupilumab have been reported previously based on data from controlled clinical trials. The GLOBOSTAD study extends the scope of these trials by providing real-world data. This analysis reports prior treatment usage in patie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d344040d2d66d3532242520d222b6980
https://doi.org/10.1093/bjd/ljac140.026
Zobrazit plný text záznamu
8
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
Autor: April Armstrong, Andrew Blauvelt, Eric L. Simpson, Catherine H. Smith, Pedro Herranz, Yoko Kataoka, Seong Jun Seo, Silvia M. Ferrucci, Jingdong Chao, Zhen Chen, Ana B. Rossi, Brad Shumel, Paul Tomondy
Publikováno v: Dermatology and Therapy
Introduction Previous drug survival studies of dupilumab in atopic dermatitis (AD) show that many patients continue treatment through 1 year, suggesting that patients experience clinically relevant benefits with long-term treatment. Methods This post
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15432eae911784e258add09f59199e64
https://pubmed.ncbi.nlm.nih.gov/34897582
Zobrazit plný text záznamu
10
Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists and Public Health (ADOI), the Italian Association of Hospital and Territorial Allergists and Immunologists (AAIITO), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), the Italian Society of Pediatric Allergy and Immunology (SIAIP), the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA), and the Italian Society of Pediatric Dermatology (SIDerP)
Autor: Calzavara-Pinton, Piergiacomo, Belloni Fortina, Anna, Bonamonte, Domenico, Marseglia, Gian Luigi, Miraglia Del Giudice, Michele, Musarra, Antonino, Nettis, Eustachio, Neri, Iria, Patruno, Cataldo, Stingeni, Luca, Peris, Ketty, Giuseppe Argenziano, Anna G Burroni, Antonio Costanzo, Antonio Cristaudo, Francesco Cusano, May El Hachem, Gabriella Fabbrocini, Silvia M Ferrucci, Cesare Filippeschi, Caterina Foti, Elena Galli, Giampiero Girolomoni, Amelia Licari, Giovanna Malara, Giuseppe Micali, Luigi Naldi, Annamaria Offidani, Michela Ortoncelli, Michele Panzone, Aurora Parodi, Annalisa Patrizi, Giovanni Pellacani, Diego G Peroni, Paolo D Pigatto, Marco Romanelli, Franco Rongioletti, Gianenrico Senna
Atopic dermatitis (AD) is a chronic inflammatory disease with increasing global incidence, which has a multifactorial pathogenesis and a variable expressivity. Clinical features of AD are different in adults compared to children, but it is well recog
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::a88783bc877ed22510f8cf588e97cc47
http://hdl.handle.net/11588/849828
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje